PLX

$2.61+1.95%visit website

Protalix BioTherapeutics, Inc.

Market Cap

$210M

Live price × SEC shares (Aug 1, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.00

60mo monthly vs SPY

P/E (TTM)

11.3

TTM to Jun 2026 · diluted EPS

P/S (TTM)

2.6

TTM to Jun 2026 · revenue

P/B

2.9

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	17,851	9,122	33,750	19,896	80,619
Cost of revenue	8,324	4,619	4,127	7,762	24,832
Research & development	4,467	5,635	5,426	4,351	19,879
Selling, general & administrative	2,929	3,526	3,051	3,111	12,617
Operating income	2,131	(4,658)	21,146	4,672	23,291
Pretax income	2,239	(4,776)	21,141	4,860	23,464
Income tax	(116)	728	2,824	1,083	4,519
Net income	2,355	(5,504)	18,317	3,777	18,945
EPS (basic) ($)	0.03		0.23	0.05	0.24
EPS (diluted) ($)	0.03		0.22	0.05	0.23
Weighted avg. shares (basic)	79,282		79,849	79,986
Weighted avg. shares (diluted)	80,815		83,049	82,560

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 12, 2026 accepted 10:59 AM ET	2.02Earnings release	Document SEC ↗
Jun 25, 2026 accepted 8:30 PM ET	5.07Shareholder vote	Document SEC ↗
May 21, 2026 accepted 11:03 AM ET	7.01Reg FD disclosure	Document SEC ↗
May 13, 2026 accepted 10:57 AM ET	2.02Earnings release	Document SEC ↗
Mar 18, 2026 accepted 10:56 AM ET	2.02Earnings release	Document SEC ↗
Mar 9, 2026 accepted 11:51 AM ET	8.01Other events	Document SEC ↗
Feb 11, 2026 accepted 10:10 PM ET	7.01Reg FD disclosure	Document SEC ↗
Jan 30, 2026 accepted 3:09 PM ET	8.01Other events	Document SEC ↗
Jan 5, 2026 accepted 11:56 AM ET	7.01Reg FD disclosure	Document SEC ↗
Nov 13, 2025 accepted 11:54 AM ET	2.02Earnings release	Document SEC ↗